Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine

调节性 T 细胞糖皮质激素诱导的亮氨酸拉链 (GILZ) 在慢性炎症肠道中的作用

基本信息

  • 批准号:
    10215504
  • 负责人:
  • 金额:
    $ 12.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-13 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Glucocorticoid-induced leucine zipper (GILZ) is a broadly-expressed transcription factor whose expression is induced via endogenous or synthetic glucocorticoid (GC) signaling through the glucocorticoid receptor (GR). GILZ is thought to meditate many of GCs’ anti-inflammatory effects in T lymphocytes, such as induction of TGFβ signaling and inhibition of NFκB, MAPK, and AP-1 pathways. Conditional deletion of GILZ in CD4+ T cells leads to enhancement of experimental dinitrobenzene sulfonic acid (DNBS)-induced colitis, a Th1-mediated form of experimental inflammatory bowel disease (IBD). Steroid hormones, including corticosteroids and sex steroid hormones such as 17β-estradiol (estrogen, E2), demonstrate considerable promiscuity in receptor binding. E2 has been shown to antagonize GILZ in human uterine epithelial cells, but little is known regarding the mechanism(s) by which it may contribute to GILZ expression and/or function in T cells. Our preliminary data reveal a robust induction of GILZ at the mRNA and protein levels in regulatory T cells (Tregs) isolated from Crohn’s disease (CD) patients and SAMP/YitFC (“SAMP”) mice, a spontaneous model of Crohn’s-like disease. GILZ upregulation (“GILZhigh”) in these Tregs was associated with a relative decrease in estrogen receptor beta (ERβ) expression, suggesting that GILZ expression in Tregs may be responsive to estrogen signaling. Furthermore, GILZhigh Tregs exhibited reduced suppressive function compared to their GILZlow counterparts, suggesting that optimal GILZ-mediated immunosuppression in Tregs may require intact ERβ signaling. Several chronic inflammatory and autoimmune diseases exhibit reductions in ERβ expression and/or activity, leading to the intriguing possibility that diminished ERβ expression contributes to inflammation via disruption of normally-protective Treg GILZ-mediated mechanisms. Our hypothesis is that the protective functions of Treg- specific GILZ require intact ERβ signaling, and therefore fail to mediated sufficient immunoprotection in ERβ-depleted environments, such as the IBD intestine. The goal of this project is to determine the mechanism(s) by which reduced ERβ-specific signaling influences the expression and function of GILZ in IBD- associated Tregs. We will make use of novel tools (GILZ transgenic and knockout mice and MaxCyte lentiviral transfection of primary human and murine T cells) to manipulate GILZ expression in ERβ-deficient versus – sufficient Tregs in order to understand how intact ERβ signaling influences the expression (Subaim 1a) and function (Subaim 1b) of Treg-specific GILZ. Leveraging a large cohort of CD patients available through the Cleveland Digestive Disease Research Core Center (DDRCC), we will apply single-cell RNA sequencing to CD patient mucosal Tregs (discarded surgical samples) in order to identify unique transcriptional signatures (Subaim 1c) associated with ERβlow/GILZhigh Tregs. These assays will provide critical data to inform future proposals focused on the intersection of E2 signaling and GILZ activity in Tregs. Successful completion of this proposal will provide mechanistic insight into the regulation of Treg GILZ expression and function via estrogen signaling. These studies will determine the link between diminished ERβ signaling, characteristic of many auto- inflammatory diseases including IBD, and glucocorticoid signaling, with an ultimate goal of developing improved personalized medicine approaches for CD patients.
项目总结/摘要 糖皮质激素诱导的亮氨酸拉链(GILZ)是一种广泛表达的转录因子,其表达与糖皮质激素诱导的亮氨酸拉链的表达相关。 通过糖皮质激素受体(GR)的内源性或合成糖皮质激素(GC)信号传导诱导。 GILZ被认为介导了GCs在T淋巴细胞中的许多抗炎作用,如诱导TGFβ 信号传导和NFκB、MAPK和AP-1通路的抑制。CD 4 + T细胞中GILZ的条件性缺失导致 增强实验性二硝基苯磺酸(DNBS)诱导的结肠炎,一种Th 1介导的 实验性炎症性肠病(IBD)。类固醇激素,包括皮质类固醇和性类固醇 激素如17β-雌二醇(雌激素,E2)在受体结合中表现出相当大的混杂性。E2 已显示拮抗人子宫上皮细胞中的GILZ,但关于GILZ的作用知之甚少。 它可能有助于T细胞中GILZ表达和/或功能的机制。我们的初步数据 揭示了在分离自人的调节性T细胞(TCLs)中在mRNA和蛋白质水平上对GILZ的稳健诱导, 克罗恩病(CD)患者和SAMP/YitFC(“SAMP”)小鼠,克罗恩病样疾病的自发模型。 在这些乳腺癌中,GILZ上调(“GILZhigh”)与雌激素受体β的相对减少有关。 (ERβ)的表达,表明TcB中GILZ的表达可能响应于雌激素信号传导。 此外,与GILZlow对应物相比,GILZhigh Tactide表现出降低的抑制功能, 这表明,在Tendon中最佳的GILZ介导的免疫抑制可能需要完整的ERβ信号传导。 几种慢性炎性和自身免疫性疾病表现出ERβ表达和/或活性的降低, 这导致了一种有趣的可能性,即ERβ表达的减少通过破坏细胞的增殖而导致炎症。 正常保护性Treg GILZ介导的机制。我们的假设是Treg的保护功能- 特异性GILZ需要完整ERβ信号传导,因此不能介导足够的免疫保护, ERβ耗尽的环境,如IBD肠道。该项目的目标是确定 降低ERβ特异性信号传导影响IBD中GILZ表达和功能的机制- 相关的Tibet。我们将利用新的工具(GILZ转基因和基因敲除小鼠和MaxCyte慢病毒 转染原代人和鼠T细胞),以操纵ERβ缺陷型与ERβ缺陷型小鼠中GILZ的表达。 足够的TdR,以了解完整的ERβ信号传导如何影响表达(Subaim 1a), Treg特异性GILZ的功能(Subaim 1b)。利用可通过以下途径获得的大量CD患者队列 克利夫兰消化疾病研究核心中心(DDRCC),我们将应用单细胞RNA测序CD 患者粘膜THBE(丢弃的手术样品),以鉴定独特的转录签名 (Subaim 1c)与ERβ低/GILZ高TdR相关。这些分析将提供关键数据,以告知未来 提案集中在Tibetan中E2信号传导和GILZ活性的交叉点上。成功完成本 该提案将提供通过雌激素调节Treg GILZ表达和功能的机制见解 发信号。这些研究将确定减少的ERβ信号传导之间的联系,这是许多自体免疫系统的特征。 炎症性疾病,包括IBD和糖皮质激素信号传导,最终目标是开发改善的 为CD患者提供个性化的治疗方法。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sam68 contributes to intestinal inflammation in experimental and human colitis.
  • DOI:
    10.1007/s00018-021-03976-7
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Goodman WA;Basavarajappa SC;Liu AR;Rodriguez FDS;Mathes T;Ramakrishnan P
  • 通讯作者:
    Ramakrishnan P
Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.
Impact of COVID-19 on Patients with Inflammatory Bowel Disease.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy Ann Goodman其他文献

Wendy Ann Goodman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy Ann Goodman', 18)}}的其他基金

Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10853530
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10574487
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10182035
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10355534
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine
调节性 T 细胞糖皮质激素诱导的亮氨酸拉链 (GILZ) 在慢性炎症肠道中的作用
  • 批准号:
    10057684
  • 财政年份:
    2020
  • 资助金额:
    $ 12.08万
  • 项目类别:
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD
克罗恩病和实验性 IBD 调节性 T 细胞功能性别差异的分子机制
  • 批准号:
    9750684
  • 财政年份:
    2015
  • 资助金额:
    $ 12.08万
  • 项目类别:
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD
克罗恩病和实验性 IBD 调节性 T 细胞功能性别差异的分子机制
  • 批准号:
    9146962
  • 财政年份:
    2015
  • 资助金额:
    $ 12.08万
  • 项目类别:
KLF2 as a Regulator of Metabolic Inflammation
KLF2 作为代谢炎症的调节剂
  • 批准号:
    8254121
  • 财政年份:
    2012
  • 资助金额:
    $ 12.08万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
  • 批准号:
    EP/Z00022X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
  • 批准号:
    AH/Y007549/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了